Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Hoa H. Le"'
Autor:
Robert Zivadinov, Alexander J. Keenan, Hoa H. Le, Maria Ait-Tihyaty, Kavita Gandhi, Matthew L. Zierhut, Elizabeth M. Salvo-Halloran, Abril Oliva Ramirez, Vivian Vuong, Sumeet Singh, Brian Hutton
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Brain volume loss (BVL) has been identified as a predictor of disability progression in relapsing multiple sclerosis (RMS). As many available disease-modifying treatments (DMTs) have shown an effect on slowing BVL, this is becomin
Externí odkaz:
https://doaj.org/article/97264d5b987049ffa4492a729b163739
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background This retrospective study examined the humanistic burden of fatigue in patients with relapsing-remitting multiple sclerosis (RRMS), compared with adults without MS, using data from the 2017 and 2019 US National Health and Wellness
Externí odkaz:
https://doaj.org/article/a171b8a054bd452eba61cf25a84c10a8
Publikováno v:
Healthcare in Low-resource Settings, Vol 3, Iss 1 (2015)
Unintended pregnancy (UIP) poses considerable humanistic and economic burden in both developed and developing countries. In the analysis described here, we evaluate the costs of unintended pregnancies based on estimates in South Africa. To estimate t
Externí odkaz:
https://doaj.org/article/cd1b8f4b53764bf38bb6fc201db0dac9
Autor:
Timothy Spittle, Noam Y. Kirson, Joshua Tseng-Tham, May Shawi, Andrea Guglielmo, John J. Sheehan, Hoa H. Le, Urvi Desai
Publikováno v:
Journal of Comparative Effectiveness Research. 10:393-407
Aim: Estimate the cost-per-remitter with esketamine nasal spray plus an oral antidepressant (ESK + oral AD) versus oral AD plus nasal placebo (oral AD + PBO) among patients with treatment-resistant depression. Patients & methods: An Excel-based model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51db06577ab3588b76d92ee3ffc64a1c
https://doi.org/10.2217/cer-2020-0276
https://doi.org/10.2217/cer-2020-0276
Autor:
Amber Salter, Alexander Keenan, Hoa H Le, Kavita Gandhi, Maria Ait-Tihyaty, Samantha Lancia, Gary R Cutter, Robert J Fox, Ruth Ann Marrie
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9:205521732311670
Background Fatigue is associated with reduced quality of life and social participation, and poor employment outcomes. However, most studies examining fatigue are limited by small sample sizes or short follow-up periods. Objective To characterize the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60703e2e88c19c216c61a5f541cee6a2
https://doi.org/10.1177/20552173231167079
https://doi.org/10.1177/20552173231167079
Autor:
Olivera Rajkovic-Hooley, Tom R. Denee, John Waller, Tom Bailey, Chloe Middleton-Dalby, Paul McCrone, Timothy Ming, Hoa H. Le, David Taylor, Qiaoyi Zhang
Publikováno v:
Current Medical Research and Opinion. 37:311-319
Major depressive disorder (MDD) is a globally prevalent chronic psychiatric illness with a significant disease impact. As many as 30% of patients with MDD do not adequately respond to two therapies and are considered to be treatment resistant. This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a00c914019cade248dc4a707821d52d
https://doi.org/10.1080/03007995.2020.1857580
https://doi.org/10.1080/03007995.2020.1857580
Publikováno v:
Multiple sclerosis and related disorders. 65
Fatigue, a common disabling symptom in multiple sclerosis (MS), is reported by the majority of patients. However, evidence on the economic burden of fatigue in MS by fatigue status is limited. This study aimed to evaluate the economic burden of fatig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c5661fd6aa53b1f0927f8bc7fccba2c
https://pubmed.ncbi.nlm.nih.gov/35843012
https://pubmed.ncbi.nlm.nih.gov/35843012
Publikováno v:
Journal of comparative effectiveness research. 11(5)
Background: Esketamine nasal spray plus an oral antidepressant is approved in adults with major depressive disorder with acute suicidal ideation or behavior (MDSI). Methods: A budget impact analysis from a US payer perspective was performed with a hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a35a9b20a97af026f8a34f8a6e6803
https://pubmed.ncbi.nlm.nih.gov/35073728
https://pubmed.ncbi.nlm.nih.gov/35073728
Autor:
Marion Azoulai, Tiphaine Lévy-Heidmann, Valentin Morisseau, Ophélie Wilczynski, Hoa H Le, Carol Jamieson, Leigh E. Charvet, Lauren B Krupp, Lindsey Lair
Publikováno v:
Multiple sclerosis and related disorders. 59
Fatigue is among the most frequent and disabling symptoms in patients with relapsing multiple sclerosis (RMS).To measure MS fatigue and its impact on daily life in a real-world US population using an MS-specific patient-reported outcome (PRO) instrum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c08b30bc17578a33a1db6fa7a09839b
https://pubmed.ncbi.nlm.nih.gov/35168093
https://pubmed.ncbi.nlm.nih.gov/35168093
Autor:
Jelena Stevanović, Marjolein Pompen, Hoa H Le, Mark H Rozenbaum, Robert G Tieleman, Maarten J Postma
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103974 (2014)
BackgroundStroke prevention is the main goal of treating patients with atrial fibrillation (AF). Vitamin-K antagonists (VKAs) present an effective treatment in stroke prevention, however, the risk of bleeding and the requirement for regular coagulati
Externí odkaz:
https://doaj.org/article/66a2246e4ad8431898941e600348e958